Check out the Inaugural "Technical Advances" article in CMGH featuring work from the Drew Lab directly comparing leading single-cell transcriptomic profiling platforms and their suitability for human colon biopsy specimens and epithelial cell profiling.

Dr. Drew along with the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO) Investigator team has published the findings of...

Selected as one of the five new Cancer Grand Challenges team, Team PROSPECT aims to address the global rise in the incidence of early...

Out this week in Nature Communications, our team describes our latest results from the COVID Symptom Study describing barriers to vaccine...

Today marked the kick off of the ambitious NPH initiative for which the Drew Lab will be supporting the New England Clinical Center, a...

Published today in Science, our first report demonstrating the power of our real-time epidemiology approach towards studying COVID-19....